Summary
Type 1 (insulin-dependent) diabetes mellitus in adolescence is associated with reduced levels of insulin-like growth factor I, elevated growth hormone concentrations and insulin resistance. In order to determine whether restoring insulin-like growth factor I levels to normal might lead to a reduction in growth hormone levels and insulin requirements, we undertook a double-blind placebo controlled study of a single s. c. dose of recombinant insulin-like growth factor I (40 μg/kg body weight) in nine late pubertal subjects with Type 1 diabetes. After administration of placebo or insulin-like growth factor I at 18.00 hours, a variable rate insulin infusion was used to maintain euglycaemia overnight. Plasma insulin-like growth factor I, growth hormone, free insulin, and intermediate metabolite concentrations were monitored throughout the study. Recombinant insulin-like growth factor I led to a rise in plasma concentrations which reached a peak at 5.5 h (413.1±28.2 ng/ml, mean±SEM). Mean growth hormone levels between 20.00 and 08.00 hours were significantly reduced after recombinant insulin-like growth factor I (19.4±4.0 compared with 33.6±5.8 mU/l; p=0.01), as were the insulin requirements for euglycaemia (0.25±0.02 compared with 0.31±0.04 mU · kg−1 · min−1; p=0.03). Plasma free insulin levels were lower after recombinant insulin-like growth factor I administration (31.9±2.7 compared with 67.9±16.0 mU/l; p=0.001) but no significant differences in ketone or lactate levels were detected. Recombinant insulin-like growth factor I in a s. c. dose of 40 μg/kg body weight leads to a significant reduction in overnight growth hormone levels and insulin requirements in adolescents with Type 1 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP (1990) Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71: 1356–1362
Batch JA, Werther GA (1992) Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes. Clin Endocrinol 36: 411–416
Fowelin J, Attvall S, von Schenck H, Smith U, Lager I (1991) Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 34: 500–506
Pal BR, Phillips PE, Matthews DR, Dunger DB (1992) Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35: 542–549
Perriello G, De Feo P, Torlone E et al. (1990) Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33: 52–59
Dunger DB, Edge JA, Pal R, Taylor AM, Holly JMP, Matthews DR (1991) Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes. Acta Paediatr Scand [Suppl] 377: 69–77
Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane VW (1984) Effect of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes. Diabetes 33: 1175–1179
Taylor AM, Dunger DB, Grant DB, Preece MA (1988) Somatomedin-C/IGF-1 measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls. Diabetes Res 9: 177–181
Matthews DR, Edge JR, Dunger DB (1990) An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents. Diabetic Med 7: 246–251
Wilton P, Sietnieks A, Gunnarsson R, Berger L, Grahnen A (1991) Pharmacokinetic profile of recombinant human insulin-like growth factor 1 subcutaneously in normal subjects. Acta Paediatr Scand [Suppl] 377: 111–114
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheetham, T.D., Jones, J., Taylor, A.M. et al. The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 678–681 (1993). https://doi.org/10.1007/BF00404081
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404081